Literature DB >> 10597748

Usefulness of the epithelial tumor marker CA-125 in non-Hodgkin's lymphoma.

M Ozgüroglu1, H Turna, G Demir, A Döventas, F Demirelli, N M Mandel, E Büyükünal, S Serdengeçti, B Berkarda.   

Abstract

CA-125, a commonly used tumor marker for epithelial ovarian cancer, is a glycoprotein found in normal tissues derived from coelomic epithelia. Increased serum levels of CA-125 have also been found in nongynecologic tumors and nonmalignant diseases involving the peritoneum. A few recent studies and sporadic case reports have reported increased CA-125 levels in patients with non-Hodgkin's lymphoma (NHL). In our study, we aimed to evaluate the serum levels of CA-125 in patients with NHL and determine its potential role to show disease activity in NHL. Serum levels of CA-125 were measured in 61 patients with NHL and were found to be correlated with clinical stage, site of involvement, and disease activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10597748     DOI: 10.1097/00000421-199912000-00014

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  3 in total

1.  The role of CA125 in clinical practice.

Authors:  E L Moss; J Hollingworth; T M Reynolds
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

2.  Ovarian cancer screening and early detection in the general population.

Authors:  Jose A Rauh-Hain; Thomas C Krivak; Marcela G Del Carmen; Alexander B Olawaiye
Journal:  Rev Obstet Gynecol       Date:  2011

3.  Identification of hypoxanthine as a urine marker for non-Hodgkin lymphoma by low-mass-ion profiling.

Authors:  Byong Chul Yoo; Sun-Young Kong; Sang-Geun Jang; Kyung-Hee Kim; Sun-A Ahn; Weon-Seo Park; Sohee Park; Tak Yun; Hyeon-Seok Eom
Journal:  BMC Cancer       Date:  2010-02-23       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.